2022
August 23, 2022
Novo Holdings acquires The Ritedose Corporation and fully automated packaging lines increased to six
Stability & Regulatory Support
January 24, 2020
ICH Stability program to support semipermeable conditions. Regulatory team supports project throughout regulatory lifecycle.
Analytical & Microbiology Support
January 24, 2020
Dedicated multidisciplinary team to support all aspects of development from method development, method validation, sterility & bioburden along with our robust microbiology lab.
Process Development & Technology Transfer
January 24, 2020
Development engineering teams lead all aspects of product development/transfers from the clinical study stage and manage projects throughout the development lifecycle, process validation & commercial launch.
2016
January 16, 2020
TRC obtains fourth ANDA and operating capacity reaches 2.1 billion units with 10 BFS machines, five fully automated packaging lines and one semi-automated packaging line
- 1
- 2
Recent Posts
- Ritedose Pharmaceuticals Launches Cromolyn Sodium Inhalation Solution, USP (20 mg/2 ml)
- Ritedose Launches Albuterol Sulfate Inhalation Solution 0.5% (5 mg/mL) to Meet National Drug Shortage
- The Ritedose Corporation Begins Production of Drug to Alleviate National Medication Shortage
- Ritedose Pharmaceuticals Launches New Product: Arformoterol Tartrate Inhalation Solution (15 mcg/2 ml)
- Ritedose Awarded 503B Compounded Medications Agreement with Premier, Inc.
Archives
Categories
Recent News
-
-
-
The Ritedose Corporation Begins Production of Drug to Alleviate National Medication Shortage Posted on 26th April, 2023
Post Categories
- In the News (13)
- Press Releases (10)
- Uncategorized (14)
Recent Comments